Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
Removing Mystery from Myeloma: Diagnosis & Treatment
Join Alicia and Shona from The Leukemia and Lymphoma Society as they speak with Dr. Racquel Innis-Shelton, Associate Professor of Medicine and Director of the University of Alabama Multiple Myeloma Clinic at the University of Alabama. This episode is the first of five that will be part of ‘Removing Mystery from Myeloma‘ series. On this episode, Dr. Innis-Shelton explains the difference between myeloma and multiple myeloma, risk factors that can affect someone’s chance of getting myeloma, signs and symptoms of myeloma, diagnosis and current and emerging treatments. Dr. Innis-Shelton also expounds on why it seems that myeloma seemingly takes longer to diagnosis and the role of ‘monoclonal gammopathy of unspecified significance’ (MGUS) within a myeloma patient. Dr. Innis-Shelton shares her concern for the low awareness of myeloma within the African-American population, especially with myeloma being the most common hematologic malignancy in African-Americans with twice the incidence of Caucasians. She strives to educate all patients about their myeloma diagnosis and stresses the importance of community and support along one’s cancer journey.
Be sure to look out for our other 4 episodes from this series in the upcoming months!
Support for this episode provided by Amgen and Takeda Oncology.
Understanding a CLL Diagnosis
Listen in as Alicia and Lizette chat with Dr. Ann LaCasce, a Program Director of the Dana-Farber/ Partners CancerCare Fellowship, the largest hematology/oncology training program in the country. While studying pre-med, Dr. LaCasce took additional classes that piqued her interest in art history. After managing an art gallery in New York for five years and returning to medical school, she found that being visually oriented allowed her to approach hematology with creativity while caring for her patients. Join in as Dr. LaCasce discusses diagnosis and treatment of chronic lymphocytic leukemia (CLL), small cell lymphocytic lymphoma (SLL), the importance of patients feeling comfortable with their healthcare team and why she prefers the term ‘active surveillance’ over ‘watch and wait’ when monitoring a patient’s disease.
Support for this episode provided by Pharmacyclics.
Treating Mantle Cell Lymphoma
Join Alicia and Lizette as they speak with Dr. Robert Chen about the treatment of mantle cell lymphoma (MCL). Dr. Chen is a hematologist/oncologist at City of Hope in Duarte, California. On this episode, Dr. Chen explains the different variables taken into consideration when choosing the proper treatment for a MCL patient. He also discusses induction chemotherapy, CAR T-cell therapy, and stem cell transplantation, explaining that although allogeneic transplant is potentially curative, it’s important to understand why it should be approached with caution.
Support for this episode provided by AstraZeneca.
Support for The Bloodline with LLS provided by Amgen, Bristol-Myers Squibb, Jazz Pharmaceuticals, Kite Pharmaceuticals, Pharmacyclics, Seattle Genetics, and Takeda Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.